早期胃癌内镜黏膜下剥离术后非治愈性切除的危险因素
Risk Factors of Non-Curative Resection after Endoscopic Submucosal Dissection for Early Gastric Cancer
DOI: 10.12677/acm.2026.161313, PDF,   
作者: 刘育池:青岛大学青岛医学院,山东 青岛;张 波, 黄留业*:青岛大学附属烟台毓璜顶医院消化内科,山东 烟台
关键词: 早期胃癌内镜黏膜下剥离术非治愈性切除危险因素预测模型Early Gastric Cancer Endoscopic Submucosal Dissection Noncurative Resection Risk Factors Prediction Model
摘要: 目的:探讨早期胃癌(Early Gastric Cancer, EGC)患者行内镜黏膜下剥离术(Endoscopic Submucosal Dissection, ESD)后非治愈性切除的危险因素,并构建术前预测模型。方法:回顾性分析2020年1月1日至2024年1月1日于烟台毓璜顶医院行ESD治疗且病理确诊为EGC的302例患者的临床资料。根据术后病理结果将患者分为治愈性切除组(Curative Resection, CR)和非治愈性切除(Non-curative Resection, NCR)组。对比分析两组患者的临床特征、内镜下表现、肿瘤病理特征及8项炎症营养指标,采用单因素和多因素Logistic回归分析筛选NCR的独立危险因素,并基于术前可获取的变量构建预测模型。结果:302例患者中,NCR组55例(18.2%)。单因素分析显示,年龄、肿瘤大小、肿瘤部位、分化程度、浸润深度、溃疡、黏膜红斑、萎缩与NCR相关(P < 0.05)。多因素分析证实,肿瘤大小(OR = 1.729, P < 0.001)、溃疡(OR = 7.379, P < 0.001)、黏膜红斑(OR = 3.624, P < 0.001)和萎缩(OR = 0.162, P < 0.001)是NCR的独立危险因素。预后营养指数(Prognostic Nutritional Index, PNI)、淋巴细胞/单核细胞比值(Lymphocyte-to-Monocyte Ratio, LMR)和中性粒细胞/淋巴细胞比值(Neutrophil-to-Lymphocyte Ratio, NLR)等炎症营养指标与NCR无显著相关性。基于年龄、肿瘤大小、肿瘤部位、溃疡、黏膜红斑、萎缩构建的诺莫图预测NCR的AUC为0.853,内部验证校准曲线显示模型具有良好的准确性与区分度。结论:肿瘤大小、溃疡、黏膜红斑和萎缩早期胃癌ESD术后NCR的独立危险因素。基于术前临床及内镜特征构建的诺莫图对NCR具有良好的预测效能,有助于术前识别高风险患者并指导个体化治疗决策。
Abstract: Objective: To investigate the risk factors for noncurative resection (NCR) after endoscopic submucosal dissection (ESD) in patients with early gastric cancer (EGC) and to develop a preoperative prediction model. Methods: A retrospective analysis was conducted on 302 EGC patients who underwent ESD at Yantai Yuhuangding Hospital between January 1, 2020, and January 1, 2024. Patients were divided into curative resection (CR) and non-curative resection (NCR) groups on the basis of postoperative pathology. Clinical characteristics, endoscopic findings, tumor pathological features, and eight inflammatory/nutritional indicators were compared between the groups. Univariate and multivariate logistic regression analyses were used to identify independent risk factors for NCR. A predictive nomogram was constructed using preoperative variables. Results: Among the 302 patients, 55 (18.2%) were in the NCR group. Univariate analysis revealed that age, tumor size, tumor location, differentiation degree, depth of invasion, ulceration, mucosal redness, and atrophy were associated with NCR (P < 0.05). Multivariate analysis confirmed that tumor size (OR = 1.729, P < 0.001), ulceration (OR = 7.379, P < 0.001), mucosal redness (OR = 3.624, P < 0.001), and atrophy (OR = 0.162, P < 0.001) were independent risk factors for NCR. Inflammatory/nutritional indices, such as the prognostic nutritional index (PNI), lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR), were not significantly correlated with the NCR. The nomogram constructed on the basis of age, tumor size, tumor location, ulceration, mucosal redness, and atrophy achieved an AUC of 0.853 for predicting NCR. Internal validation via bootstrap resampling revealed good calibration and discrimination. Conclusion: Tumor size, ulceration, mucosal redness, and atrophy are independent risk factors for NCR after ESD for EGC. The preoperative nomogram based on clinical and endoscopic features demonstrated good predictive performance for NCR, which can assist in identifying high-risk patients preoperatively and guiding individualized treatment strategies.
文章引用:刘育池, 张波, 黄留业. 早期胃癌内镜黏膜下剥离术后非治愈性切除的危险因素[J]. 临床医学进展, 2026, 16(1): 2515-2526. https://doi.org/10.12677/acm.2026.161313

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[3] 李茁钰, 刘凯, 张维汉, 等. 全球及中国胃癌的流行病学特点及趋势: 2018-2022《全球癌症统计报告》解读[J]. 中国普外基础与临床杂志, 2024, 31(10): 1236-1245.
[4] Wu, Y.C., Cai, Y.L., Rong, L., et al. (2020) Characteristics of Lymph Node Metastasis and Evaluating the Efficacy of Endoscopic Submucosal Dissection in Early Gastric Cancer. Journal of Peking University, 52, 1093-1097.
[5] 郑承超, 曾庆新, 彭如洁. 消化内镜黏膜下剥离术治疗早期胃癌的效果观察[J]. 中国卫生标准管理, 2024, 15(1): 119-122.
[6] Liu, J.M., Liang, L., Zhang, J.X., et al. (2023) Pathological Evaluation of Endoscopic Submucosal Dissection for Early Gastric Cancer and Precancerous Lesion in 411 Cases. Journal of Peking University, 55, 299-307.
[7] Bauer, A.T., Gorzelanny, C., Gebhardt, C., Pantel, K. and Schneider, S.W. (2022) Interplay between Coagulation and Inflammation in Cancer: Limitations and Therapeutic Opportunities. Cancer Treatment Reviews, 102, Article 102322. [Google Scholar] [CrossRef] [PubMed]
[8] 李启松, 崔玉宝. 炎症促进肿瘤发生发展的研究进展[J]. 医学综述, 2015, 21(16): 2918-2920.
[9] Maiorino, L., Daßler-Plenker, J., Sun, L. and Egeblad, M. (2022) Innate Immunity and Cancer Pathophysiology. Annual Review of Pathology: Mechanisms of Disease, 17, 425-457. [Google Scholar] [CrossRef] [PubMed]
[10] Fiflis, S., Christodoulidis, G., Papakonstantinou, M., Giakoustidis, A., Koukias, S., Roussos, P., et al. (2024) Prognostic Nutritional Index in Predicting Survival of Patients with Gastric or Gastroesophageal Junction Adenocarcinoma: A Systematic Review. World Journal of Gastrointestinal Oncology, 16, 514-526. [Google Scholar] [CrossRef] [PubMed]
[11] Mei, P., Feng, W., Zhan, Y. and Guo, X. (2023) Prognostic Value of Lymphocyte-to-Monocyte Ratio in Gastric Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Frontiers in Immunology, 14, Article ID: 1321584. [Google Scholar] [CrossRef] [PubMed]
[12] Szor, D.J., Dias, A.R., Pereira, M.A., Ramos, M.F.K.P., Zilberstein, B., Cecconello, I., et al. (2018) Prognostic Role of Neutrophil/Lymphocyte Ratio in Resected Gastric Cancer: A Systematic Review and Meta-Analysis. Clinics, 73, e360. [Google Scholar] [CrossRef] [PubMed]
[13] 熊建平, 田艳涛. 胃癌炎症相关预后评价体系的构建、优化与创新[J]. 中国医学前沿杂志, 2022, 14(12): 11-14+4.
[14] 张萌. 术前血小板分布宽度(PDW)与中性粒细胞-淋巴细胞比率(NLR)联合在胃癌患者预后中的应用价值[D]: [硕士学位论文]. 合肥: 安徽医科大学, 2022.
[15] 周发权, 陈师, 孙红玉, 等. 系统免疫炎症指数与胃癌患者预后关系的Meta分析[J]. 中国普通外科杂志, 2021, 30(10): 1142-1150.
[16] Niu, Z., Lin, L., Peng, H., Zheng, X., Wang, M., Sun, F., et al. (2025) The Prognostic Value of Systemic Inflammation Response Index in Digestive System Carcinomas: A Systematic Review and Meta-Analysis. BMC Gastroenterology, 25, Article No. 34. [Google Scholar] [CrossRef] [PubMed]
[17] Japanese Gastric Cancer Association (2022) Japanese Gastric Cancer Treatment Guidelines 2021 (6th Edition). Gastric Cancer, 26, 1-25. [Google Scholar] [CrossRef] [PubMed]
[18] 中华医学会肿瘤学分会, 中华医学会杂志社. 中华医学会胃癌临床诊疗指南(2021版) [J]. 中华医学杂志, 2022, 102(16): 1169-1189.
[19] 赫捷, 陈万青, 李兆申, 等. 中国胃癌筛查与早诊早治指南(2022, 北京) [J]. 中国肿瘤, 2022, 31(7): 488-527.
[20] Zhao, Y. and Wang, C. (2018) Long-Term Clinical Efficacy and Perioperative Safety of Endoscopic Submucosal Dissection versus Endoscopic Mucosal Resection for Early Gastric Cancer: An Updated Meta-Analysis. BioMed Research International, 2018, Article ID: 3152346. [Google Scholar] [CrossRef] [PubMed]
[21] 周红, 郭春光, 陈应泰, 等. 早期胃癌非治愈性内镜黏膜下剥离术后的治疗策略研究[J]. 2019, 41(11): 865-869.
[22] 宋书彬, 刘宏刚, 薛英威. 进展期胃癌患者预后营养指数的临床意义[J]. 中华胃肠外科杂志, 2018, 21(2): 180-184.
[23] 刘燕燕, 张明军. 预后营养指数对进展期胃癌患者术后并发症及短期生存率的影响分析[J]. 临床输血与检验, 2022, 24(2): 230-235.
[24] Jing, Y., Ren, M., Li, X., Sun, X., Xiao, Y., Xue, J., et al. (2024) The Effect of Systemic Immune-Inflammatory Index (SII) and Prognostic Nutritional Index (PNI) in Early Gastric Cancer. Journal of Inflammation Research, 17, 10273-10287. [Google Scholar] [CrossRef] [PubMed]
[25] Pan, Y., Jia, Z., Cao, D., Wu, Y., Jiang, J., Wen, S., et al. (2018) Preoperative Lymphocyte-to-Monocyte Ratio (LMR) Could Independently Predict Overall Survival of Resectable Gastric Cancer Patients. Medicine, 97, e13896. [Google Scholar] [CrossRef] [PubMed]
[26] Tan, S., Zheng, Q., Zhang, W., Zhou, M., Xia, C. and Feng, W. (2024) Prognostic Value of Inflammatory Markers NLR, PLR, and LMR in Gastric Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-Analysis and Systematic Review. Frontiers in Immunology, 15, Article ID: 1408700. [Google Scholar] [CrossRef] [PubMed]
[27] Toyokawa, T., Inaba, T., Omote, S., Okamoto, A., Miyasaka, R., Watanabe, K., et al. (2015) Risk Factors for Non-Curative Resection of Early Gastric Neoplasms with Endoscopic Submucosal Dissection: Analysis of 1,123 Lesions. Experimental and Therapeutic Medicine, 9, 1209-1214. [Google Scholar] [CrossRef] [PubMed]
[28] Kim, E.H., Park, J.C., Song, I.J., Kim, Y.J., Joh, D.H., Hahn, K.Y., et al. (2017) Prediction Model for Non-Curative Resection of Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer. Gastrointestinal Endoscopy, 85, 976-983. [Google Scholar] [CrossRef] [PubMed]
[29] Lee, S.H., Kim, M.C., Jeon, S.W., Lee, K.N., Park, J.J. and Hong, S.J. (2020) Risk Factors and Clinical Outcomes of Non-Curative Resection in Patients with Early Gastric Cancer Treated with Endoscopic Submucosal Dissection: A Retrospective Multicenter Study in Korea. Clinical Endoscopy, 53, 196-205. [Google Scholar] [CrossRef] [PubMed]
[30] Ohno, A., Miyoshi, J., Kato, A., Miyamoto, N., Yatagai, T., Hada, Y., et al. (2020) Endoscopic Severe Mucosal Atrophy Indicates the Presence of Gastric Cancer after Helicobacter Pylori Eradication-Analysis Based on the Kyoto Classification. BMC Gastroenterology, 20, Article No. 232. [Google Scholar] [CrossRef] [PubMed]
[31] 周璇, 李洪, 冯志杰, 等. 内镜黏膜下剥离术治疗早期胃癌非治愈性切除相关危险因素分析[J]. 河北医科大学学报, 2022, 43(7): 787-791.
[32] Ma, X., Zhang, Q., Zhu, S., Zhang, S. and Sun, X. (2021) Risk Factors and Prediction Model for Non-Curative Resection of Early Gastric Cancer with Endoscopic Resection and the Evaluation. Frontiers in Medicine, 8, Article ID: 637875. [Google Scholar] [CrossRef] [PubMed]
[33] Guo, L., Ding, Y., Wen, J., Miao, M., Hu, K. and Ye, G. (2025) Risk Factors and Predictive Nomogram for Non-Curative Resection in Patients with Early Gastric Cancer Treated with Endoscopic Submucosal Dissection: A Retrospective Cohort Study. World Journal of Surgical Oncology, 23, Article No. 213. [Google Scholar] [CrossRef] [PubMed]
[34] Japanese Gastric Cancer Association (2020) Japanese Gastric Cancer Treatment Guidelines 2018 (5th Edition). Gastric Cancer, 24, 1-21. [Google Scholar] [CrossRef] [PubMed]
[35] Ohara, Y., Toshikuni, N., Matsueda, K., Mouri, H. and Yamamoto, H. (2016) The Superficial Elevated and Depressed Lesion Type Is an Independent Factor Associated with Non-Curative Endoscopic Submucosal Dissection for Early Gastric Cancer. Surgical Endoscopy, 30, 4880-4888. [Google Scholar] [CrossRef] [PubMed]
[36] 董娜, 马甘青, 王露露, 等. 早期胃癌ESD术后非治愈性切除预测模型的建立与验证[J]. 协和医学杂志, 2024, 15(1): 109-116.